The Oncology Nursing Forum (ONF) publishes peer-reviewed findings from oncology nursing research and supports the translation of research evidence to practice and policy. ONF fosters health equity for individuals, families, and communities affected by cancer through dissemination of research that transforms cancer care in health systems and communities.
Learn more about content and submission guidelines here or go to Editorial Manager to submit your manuscript for consideration.
Manuscripts are accepted for consideration with the understanding that they are contributed solely to this journal, that the material is original, and that the articles have not been published previously. All manuscripts will be reviewed for originality. Manuscripts found to plagiarize the work of others will be prohibited from publication in ONF or the Clinical Journal of Oncology Nursing.
If a work has multiple authors, the paper is reviewed on the assumption that all authors have granted approval for submission. All submitted papers are subject to blind peer review. Papers will be judged on the quality of the work and suitability for the audience. Questions should be sent directly to
ONF Editor
Debra Lyon, RN, PhD, FNP-BC, FAAN
ONFEditor@ons.org
Papers should be prepared using standard manuscript form according to the Publication Manual of the American Psychological Association (APA), 7th edition (2019). (Visit www.apastyle.org for assistance.) Length should be 12–15 pages (4,000 words), exclusive of tables, figures, and references. Integrative reviews are limited to 5,000 words, exclusive of tables, figures, and references.
Title Page: Include names, credentials, titles, and affiliations of all authors.
Authorship/Contributors: All authors must contribute significantly to the manuscript and identify those contributions when prompted via the author form emailed to each author upon manuscript submission; authorship contributions are conceptualization and design, data collection, statistical support, analysis, and manuscript preparation. Those who do not meet authorship criteria should instead be acknowledged as contributors along with their contributions (e.g., recruitment, technical assistance).
The Oncology Nursing Society, Oncology Nursing Foundation, and Oncology Nursing Certification Corporation follow the American Nurses Association/American Nurses Credentialing Center (ANA/ANCC) recommendation for the listing of credentials. When submitting your credentials, please do so in the order listed below:
More information on displaying your credentials in this order can be found here. Please note that credentials may be subject to editing for style and length.
Structured Abstracts: An abstract is required for all articles and is limited to 200 words.
Quantitative Research: The following headings for reports of quantitative research must be included.
Qualitative Research: The following headings for reports of qualitative research must be included.
Integrative/Systematic Reviews: Integrative reviews are limited to 5,000 words, exclusive of tables, figures, and references. In addition, authors should ensure that these reviews follow the PRISMA 2009 Checklist. For a full description regarding preparation of an integrative review, see: Whittmore, E.R., & Knafl, K. (2005). The integrative review: Updated methodology. Journal of Advanced Nursing,52, 546–553.
The following headings must be included in an abstract for an integrative review.
Mixed Methods: The following headings for mixed methods research must be included.
Research Briefs: Preliminary research, pilot studies, and studies with very small samples or negative results may be submitted for publication consideration as Research Briefs. These brief reports of research should not exceed 1,500 words, exclusive of tables, figures, and references. They may be accompanied by a maximum of two tables or figures. Include a structured abstract (200 words maximum) with Objectives, Sample and Setting, Methods and Variables, Results, and Implications for Nursing. Three Knowledge Translation statements indicating new knowledge should be included. A maximum of 15 key references may be included. In addition to newly submitted manuscripts, full-length research manuscripts that previously have been deferred through the ONF peer review process may be reworked and resubmitted for consideration as a Research Brief.
Keywords: Please include three to six keywords. For examples, visit the MeSH Browser.
Text: Use headings and subheadings as appropriate. Include the names of the institutions participating in the study.
Implications for Nursing: Authors MUST include a section on "Implications for Nursing" after the Discussion and before the Conclusion. This section must highlight how the findings of the research or review can be used to change nursing practice or describe important knowledge that has the potential to increase nurses' knowledge on the topic. Manuscripts that omit this section will not be considered for publication.
Patient Confidentiality: All patient information included in manuscripts, tables, or figures must be de-identified to avoid compromising patient privacy and confidentiality. Only those details essential for understanding and interpreting a specific case report or case series should be provided.
Tables: Each should be typed, double spaced on separate pages placed at the end of the text. Every table must be referred to in the text.
Figures: Include on separate pages at the end of the manuscript. Every figure must be referred to in the text.
References: Authors are responsible for the accuracy and correct formatting of all reference citations. References will be checked for accuracy at the time of editing. Manuscripts found to contain errors are subject to delays in publication.
Permissions: The author is responsible for obtaining written permissions from the copyright owner for the use of any material (e.g., text, tables, figures, forms) previously published or printed elsewhere and to bear the cost, if any, of using the material. Permission is required for both print and electronic use. Original letters granting permission must be submitted when the final manuscript is uploaded. If the manuscript reports the results of an investigational study involving human subjects, the text must include a statement indicating approval by an institutional review board and cite its name, as well as noting informed consent when appropriate. Authors must obtain and forward a signed statement of informed consent to publish in print and online patient descriptions or case studies, photographs, and pedigrees from all individuals or parents or legal guardians of minors who can be identified in such written descriptions, photographs, or pedigrees. Such individuals should be shown the manuscript before its submission.
Acknowledgments: Any acknowledgments should be submitted with the manuscript.
Dissertations and Theses: A thesis or dissertation in entirety is not appropriate for submission to the Oncology Nursing Forum. Manuscript submissions that are substantially similar to or the same as a previously published dissertation or thesis will not be considered for publication. Text, tables, figures, etc., should be paraphrased to avoid duplication (self-plagiarism) and content should be substantially condensed. Submissions that fail to comply with this policy will be removed from publication consideration.
Online Manuscript Submission: All manuscripts must be submitted electronically via Editorial Manager. Complete instructions are provided, and assistance is available by contacting pubONF@ons.org.
All manuscript submissions (both original and revisions) should include the title page (including author names, credentials, titles, affiliations, and email addresses), the abstract, text, references, and all tables and figures. Do not blind the manuscript. (Note: Even though the title, abstract, and authors are entered into the information pages, they must still be included with the manuscript files.)
Author Rights: ONS grants the author the nonexclusive right to (a) reproduce, distribute photocopies of, and publicly display the article in the course of nonprofit teaching and research activities; (b) post the article on his or her personal website or that of the author's employer, provided any such site has commercially reasonable safeguards, including password protection, in place to protect against unauthorized copying or distribution of content; and (c) prepare, reproduce, distribute, and publicly display derivative works from the article, provided that, with respect to (a), (b), and (c) above, ONF is cited as the source of first publication of the article and that ONS is clearly indicated as the owner of the copyrights in the article. The sharing of any full-text version of the article via or facilitated by ResearchGate or any other social networking website is strictly prohibited. In compliance with National Institutes of Health funding requirements, and no sooner than six months after the article's publication, the author is permitted to post on PubMed Central the original draft of the article submitted for publication.
Financial Disclosure: Information for all contributing authors must be entered into the manuscript information pages. Upon submission of a manuscript, each author will receive an automated email, providing a link to an author copyright and disclosure form. This form transfers copyright to the Oncology Nursing Society. All authors must submit the form before the manuscript can proceed to peer review. If the manuscript is not accepted, copyright will transfer back to the authors.
Each author must disclose any financial interest in products mentioned in the manuscript or in the company that manufactures the products, as well as any compensation received for producing the manuscript. A submitted manuscript that is the result of funded research must cite the funding source on the title page. A manuscript that originated as a thesis or dissertation prepared by an author on an educational scholarship must cite the name of the scholarship. In general, this disclosure will not preclude publication in ONF providing that the manuscript meets the appropriate standards for acceptance. When appropriate, this information is shared with ONF reviewers and readers.
NIH Funding: Authors receiving government funding are required to comply with all of the terms of the NIH Public Access Policy, including submitting their funded articles to NIH for posting on PubMed Central. Authors are permitted to post the original draft of the article on PubMed Central no sooner than six months after the article's publication.
Plagiarism: All manuscripts will be reviewed for originality with a plagiarism software product. Manuscripts found to plagiarize the work of others will be prohibited from publication in ONF.
Letters to the Editor: Selection of letters to be published is the decision of the editor. For acceptance, letters must be signed. All letters are subject to editing. A letter that questions, criticizes, or responds to a previously published article automatically will be sent to the author of that article for a reply. This type of collegial exchange is encouraged. Send letters to ONFEditor@ons.org.
Online Versus Print Publication: Selection of articles for print versus online publication is at the discretion of the editor.
The FAQs below are divided by phase of the publishing process. Or, contact us at pubONF@ons.org.
Include your manuscript and any tables or figures, as well as the following:
We do not limit the number of authors; however, each author should have participated sufficiently in manuscript preparation. Contributors, such as those who provide technical help, general support, etc., should be listed in an acknowledgment.
There are no author or page fees.
A thesis or dissertation in entirety is not appropriate for submission. Manuscripts that are substantially similar to or the same as a previously published dissertation or thesis will not be considered for publication. Text, tables, figures, etc., should be paraphrased to avoid duplication (self-plagiarism) and content should be substantially condensed.
Please contact pubONF@ons.org to have the author status reset.
Ensure you are not already logged in to Editorial Manager when you click the link. If you are not logged in to an existing account and problems persist, contact pubONF@ons.org for assistance.
Selection of articles for print versus online publication is at the discretion of the editor.
Manuscripts do not proceed to the editor or peer reviewers until all authors have confirmed they are affiliated with the manuscript and completed their conflict of interest and disclosure. This status indicates one author (or more) has not completed those required documents.
There are two possibilities: (a) One author or more has not confirmed or has denied affiliation with the manuscript or (b) one author or more has not completed the conflict of interest and disclosure information. If this is not completed for 3-4 weeks, the submission is removed from consideration.
Once a manuscript is removed, it is deleted from the system and cannot be reinstated. The manuscript can be submitted again, and all authors will need to confirm their manuscript affiliation and submit their conflict of interest and disclosure information.
The average time from submission to first decision is 4-6 weeks. For the status of your specific manuscript, contact pubONF@ons.org.
Authors must acquire and provide permissions for all figures and tables they want to use that have been previously published. This includes work created by a colleague, coworker, or friend who gave verbal permission but is not an author. Copyright may be held by a journal, institution, or individual. More information to help you determine whether the content requires permission is available here.
If we cannot definitively determine whether a table or figure is original, we will ask for copyright permission as a precaution. If the content is original, notify us at pubONF@ons.org.
Authors have at least three days to reply but will be provided a specific deadline with the article layout. Please adhere to this timeline to avoid delaying publication.
Please provide us with the dates of your anticipated scheduling conflicts. We may be able to adjust the production schedule to accommodate you.
Beginning in 2025, for compliance with the U.S. Office of Science and Technology Policy, if your manuscript is supported by federal funding, it must be made publicly accessible, without an embargo or cost. Your manuscript will still go through the peer review process, but it will be fast-tracked and posted online. It will then be slated for print publication in the next available print issue.
Authors are not permitted to share the full text of their article on any social media or third-party website but may provide links to their online publications.
Timelines can vary but generally look something like this: